Stella Okoli’s $23 million plant to boost pharma self-sufficiency in Nigeria
Emzor is investing $23 million in Nigeria’s first API plant to cut drug imports, lower costs, and boost medicine security.
Stella Okoli
Nigerian businesswoman Stella Okoli’s Emzor to open $23 million API plant in late 2025
The plant, slated to begin local production in the fourth quarter of this year, marks a significant step toward reducing Nigeria’s reliance on imported medicines.
Nigerian pharma tycoon Stella Okoli, U.S. gov’t partner to combat malnutrition
Emzor, which Okoli owns, will partner with the U.S. government to establish a processing facility for medical-grade groundnut paste.
7 pharma multimillionaires in Africa you should know
Meet seven African entrepreneurs who founded pharma companies worth at least $50 million.